6/ We also took a deeper dive into the top 3 blockbusters in 2023: Keytruda from Merck $MRK , Humira from AbbVie $ABBV , and Ozempic from Novo Nordisk $NVO . Ozempic was used off-label for obesity, but it notched a record for 6th year sales of any drug product in history.

7/ Many more insights in the article. This scatter plot near the end is interactive (as are all graphics). It captures every blockbuster in 2023 ranked by Total Sales, U.S. Sales, and Rest of World Sales. Blockbusters with >$5B in revenue from: ➡️ U.S. = 15 ➡️ Ex-U.S. = 3